These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 19032414

  • 1. Cytomegalovirus infection in children who underwent hematopoietic stem cell transplantation at a single center: a retrospective study of the risk factors.
    Yoon HS, Lee JH, Choi ES, Seo JJ, Moon HN, Kim MN, Im HJ.
    Pediatr Transplant; 2009 Nov; 13(7):898-905. PubMed ID: 19032414
    [Abstract] [Full Text] [Related]

  • 2. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
    Almyroudis NG, Jakubowski A, Jaffe D, Sepkowitz K, Pamer E, O'Reilly RJ, Papanicolaou GA.
    Transpl Infect Dis; 2007 Dec; 9(4):286-94. PubMed ID: 17511819
    [Abstract] [Full Text] [Related]

  • 3. High-dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral blood stem cell transplantation.
    Hazar V, Kansoy S, Küpesiz A, Aksoylar S, Kantar M, Yeşilipek A.
    Bone Marrow Transplant; 2004 May; 33(9):931-5. PubMed ID: 15034541
    [Abstract] [Full Text] [Related]

  • 4. Cytomegalovirus infections in allogeneic stem cell recipients after reduced-intensity or myeloablative conditioning assessed by quantitative PCR and pp65-antigenemia.
    Schetelig J, Oswald O, Steuer N, Radonic A, Thulke S, Held TK, Oertel J, Nitsche A, Siegert W.
    Bone Marrow Transplant; 2003 Oct; 32(7):695-701. PubMed ID: 13130317
    [Abstract] [Full Text] [Related]

  • 5. Cytomegalovirus (CMV) infections in children undergoing hematopoetic stem cell transplantation.
    Zaucha-Prazmo A, Wójcik B, Drabko K, Choma M, Kowalczyk JR.
    Pediatr Hematol Oncol; 2005 Jun; 22(4):271-6. PubMed ID: 16020113
    [Abstract] [Full Text] [Related]

  • 6. Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation.
    Yanada M, Yamamoto K, Emi N, Naoe T, Suzuki R, Taji H, Iida H, Shimokawa T, Kohno A, Mizuta S, Maruyama F, Wakita A, Kitaori K, Yano K, Hamaguchi M, Hamajima N, Morishima Y, Kodera Y, Sao H, Morishita Y.
    Bone Marrow Transplant; 2003 Oct; 32(8):801-7. PubMed ID: 14520425
    [Abstract] [Full Text] [Related]

  • 7. Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients.
    Matsumura T, Narimatsu H, Kami M, Yuji K, Kusumi E, Hori A, Murashige N, Tanaka Y, Masuoka K, Wake A, Miyakoshi S, Kanda Y, Taniguchi S.
    Biol Blood Marrow Transplant; 2007 May; 13(5):577-83. PubMed ID: 17448917
    [Abstract] [Full Text] [Related]

  • 8. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
    Huang XJ, Xu LP, Ren HY, Zhang YC, Guo NL, Lu DP.
    Zhonghua Yi Xue Za Zhi; 2003 May 10; 83(9):766-9. PubMed ID: 12899755
    [Abstract] [Full Text] [Related]

  • 9. Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: single-centre experience.
    Piñana JL, Martino R, Barba P, Margall N, Roig MC, Valcárcel D, Sierra J, Rabella N.
    Bone Marrow Transplant; 2010 Mar 10; 45(3):534-42. PubMed ID: 19668235
    [Abstract] [Full Text] [Related]

  • 10. Cytomegalovirus antigenemia and outcomes of patients undergoing allogeneic peripheral blood stem cell transplantation: effects of long-term high-dose acyclovir prophylaxis and preemptive ganciclovir treatment.
    Hazar V, Ugur A, Colak D, Saba R, Tezcan G, Kupesiz A, Karadogan I, Gultekin M, Yesilipek A, Undar L.
    Jpn J Infect Dis; 2006 Aug 10; 59(4):216-21. PubMed ID: 16936338
    [Abstract] [Full Text] [Related]

  • 11. Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: a single-center experience.
    Manteiga R, Martino R, Sureda A, Labeaga R, Brunet S, Sierra J, Rabella N.
    Bone Marrow Transplant; 1998 Nov 10; 22(9):899-904. PubMed ID: 9827819
    [Abstract] [Full Text] [Related]

  • 12. Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan.
    Kanda Y, Mineishi S, Saito T, Seo S, Saito A, Suenaga K, Ohnishi M, Niiya H, Nakai K, Takeuchi T, Kawahigashi N, Shoji N, Ogasawara T, Tanosaki R, Kobayashi Y, Tobinai K, Kami M, Mori S, Suzuki R, Kunitoh H, Takaue Y.
    Bone Marrow Transplant; 2001 Feb 10; 27(4):437-44. PubMed ID: 11313674
    [Abstract] [Full Text] [Related]

  • 13. Cytomegalovirus infection in children undergoing hematopoietic stem cell transplantation in Chile.
    Paris C, Kopp K, King A, Santolaya ME, Zepeda AJ, Palma J.
    Pediatr Blood Cancer; 2009 Sep 10; 53(3):453-8. PubMed ID: 19418548
    [Abstract] [Full Text] [Related]

  • 14. Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogeneic PBSCT.
    Trenschel R, Ross S, Hüsing J, Ottinger H, Elmaagacli A, Roggendorf M, Schaefer UW, Runde V.
    Bone Marrow Transplant; 2000 Mar 10; 25(6):665-72. PubMed ID: 10734302
    [Abstract] [Full Text] [Related]

  • 15. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources.
    Walker CM, van Burik JA, De For TE, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2007 Sep 10; 13(9):1106-15. PubMed ID: 17697973
    [Abstract] [Full Text] [Related]

  • 16. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
    Orlić P, Dvornik S, Husnjak SC, Aralica M, Orlić L, Zivcić-Cosić S, Sladoje-Martinović B, Fućak M.
    Acta Med Croatica; 2003 Sep 10; 57(1):49-52. PubMed ID: 12876863
    [Abstract] [Full Text] [Related]

  • 17. High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation.
    Asano-Mori Y, Oshima K, Sakata-Yanagimoto M, Nakagawa M, Kandabashi K, Izutsu K, Hangaishi A, Motokura T, Chiba S, Kurokawa M, Hirai H, Kanda Y.
    Bone Marrow Transplant; 2005 Nov 10; 36(9):813-9. PubMed ID: 16151428
    [Abstract] [Full Text] [Related]

  • 18. HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation.
    Du J, Liu J, Gu J, Zhu P.
    Biol Blood Marrow Transplant; 2007 Dec 10; 13(12):1417-21. PubMed ID: 18022570
    [Abstract] [Full Text] [Related]

  • 19. [Application of real time polymerase chain reaction to the diagnosis and treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation].
    Chen H, Liu KY, Xu LP, Liu DH, Chen YH, Zhao XS, Yu L, Han W, Zhang XH, Wang Y, Chen Y, Huang XJ.
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb 10; 30(2):77-81. PubMed ID: 19563015
    [Abstract] [Full Text] [Related]

  • 20. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
    Bordon V, Bravo S, Van Renterghem L, de Moerloose B, Benoit Y, Laureys G, Dhooge C.
    Transpl Infect Dis; 2008 Feb 10; 10(1):19-23. PubMed ID: 17511814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.